Home > > Global Medical Cannabis Market Report
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: GLOBAL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 3.1. OVERVIEW 3.2. BUDS/ MARIJUANA POWDER 3.2.1. BUDS/ MARIJUANA POWDER MARKET, BY REGION 3.2.1.1. NORTH AMERICA BUDS/ MARIJUANA POWDER MARKET, BY COUNTRY 3.2.1.2. EUROPE BUDS/ MARIJUANA POWDER MARKET, BY COUNTRY 3.2.1.3. ASIA BUDS/ MARIJUANA POWDER MARKET, BY COUNTRY 3.2.1.4. MIDDLE EAST & AFRICA BUDS/ MARIJUANA POWDER MARKET, BY COUNTRY 3.3. CANNABIS EXTRACTS 3.3.1. CANNABIS EXTRACTS MARKET, BY REGION 3.3.1.1. NORTH AMERICA CANNABIS EXTRACTS MARKET, BY COUNTRY 3.3.1.2. EUROPE CANNABIS EXTRACTS MARKET, BY COUNTRY 3.3.1.3. ASIA CANNABIS EXTRACTS MARKET, BY COUNTRY 3.3.1.4. MIDDLE EAST & AFRICA CANNABIS EXTRACTS MARKET, BY COUNTRY CHAPTER 4: GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION 4.1. OVERVIEW 4.2. CHRONIC PAIN 4.2.1. CHRONIC PAIN MARKET, BY REGION 4.2.1.1. NORTH AMERICA CHRONIC PAIN MARKET, BY COUNTRY 4.2.1.2. EUROPE CHRONIC PAIN MARKET, BY COUNTRY 4.2.1.3. ASIA CHRONIC PAIN MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA CHRONIC PAIN MARKET, BY COUNTRY 4.3. MENTAL DISORDERS 4.3.1. MENTAL DISORDERS MARKET, BY REGION 4.3.1.1. NORTH AMERICA MENTAL DISORDERS MARKET, BY COUNTRY 4.3.1.2. EUROPE MENTAL DISORDERS MARKET, BY COUNTRY 4.3.1.3. ASIA MENTAL DISORDERS MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA MENTAL DISORDERS MARKET, BY COUNTRY 4.4. CANCER 4.4.1. CANCER MARKET, BY REGION 4.4.1.1. NORTH AMERICA CANCER MARKET, BY COUNTRY 4.4.1.2. EUROPE CANCER MARKET, BY COUNTRY 4.4.1.3. ASIA CANCER MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA CANCER MARKET, BY COUNTRY 4.5. OTHER APPLICATIONS 4.5.1. OTHER APPLICATIONS MARKET, BY REGION 4.5.1.1. NORTH AMERICA OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.2. EUROPE OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.3. ASIA OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA OTHER APPLICATIONS MARKET, BY COUNTRY CHAPTER 5: GLOBAL MEDICAL CANNABIS MARKET, BY END USER 5.1. OVERVIEW 5.2. PHARMACEUTICALS 5.2.1. PHARMACEUTICALS MARKET, BY REGION 5.2.1.1. NORTH AMERICA PHARMACEUTICALS MARKET, BY COUNTRY 5.2.1.2. EUROPE PHARMACEUTICALS MARKET, BY COUNTRY 5.2.1.3. ASIA PHARMACEUTICALS MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA PHARMACEUTICALS MARKET, BY COUNTRY 5.3. RESEARCH AND DEVELOPMENT CENTERS 5.3.1. RESEARCH AND DEVELOPMENT CENTERS MARKET, BY REGION 5.3.1.1. NORTH AMERICA RESEARCH AND DEVELOPMENT CENTERS MARKET, BY COUNTRY 5.3.1.2. EUROPE RESEARCH AND DEVELOPMENT CENTERS MARKET, BY COUNTRY 5.3.1.3. ASIA RESEARCH AND DEVELOPMENT CENTERS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA RESEARCH AND DEVELOPMENT CENTERS MARKET, BY COUNTRY CHAPTER 6: GLOBAL MEDICAL CANNABIS MARKET, BY REGION 6.1. OVERVIEW 6.2. NORTH AMERICA 6.2.1. NORTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.2.2. NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION 6.2.3. NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER 6.2.4. NORTH AMERICA MEDICAL CANNABIS MARKET, BY COUNTRY 6.2.4.1. U.S. 6.2.4.1.1. U.S. MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.2.4.1.2. U.S. MEDICAL CANNABIS MARKET, BY APPLICATION 6.2.4.1.3. U.S. MEDICAL CANNABIS MARKET, BY END USER 6.2.4.2. CANADA 6.2.4.2.1. CANADA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.2.4.2.2. CANADA MEDICAL CANNABIS MARKET, BY APPLICATION 6.2.4.2.3. CANADA MEDICAL CANNABIS MARKET, BY END USER 6.3. EUROPE 6.3.1. EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.2. EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.3. EUROPE MEDICAL CANNABIS MARKET, BY END USER 6.3.4. EUROPE MEDICAL CANNABIS MARKET, BY COUNTRY 6.3.4.1. GERMANY 6.3.4.1.1. GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.4.1.2. GERMANY MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.4.1.3. GERMANY MEDICAL CANNABIS MARKET, BY END USER 6.3.4.2. U.K. 6.3.4.2.1. U.K. MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.4.2.2. U.K. MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.4.2.3. U.K. MEDICAL CANNABIS MARKET, BY END USER 6.3.4.3. DENMARK 6.3.4.3.1. DENMARK MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.4.3.2. DENMARK MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.4.3.3. DENMARK MEDICAL CANNABIS MARKET, BY END USER 6.3.4.4. ITALY 6.3.4.4.1. ITALY MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.4.4.2. ITALY MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.4.4.3. ITALY MEDICAL CANNABIS MARKET, BY END USER 6.3.4.5. POLAND 6.3.4.5.1. POLAND MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.4.5.2. POLAND MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.4.5.3. POLAND MEDICAL CANNABIS MARKET, BY END USER 6.3.4.6. REST OF EUROPE 6.3.4.6.1. REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.4.6.2. REST OF EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.4.6.3. REST OF EUROPE MEDICAL CANNABIS MARKET, BY END USER 6.4. ASIA 6.4.1. ASIA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.4.2. ASIA MEDICAL CANNABIS MARKET, BY APPLICATION 6.4.3. ASIA MEDICAL CANNABIS MARKET, BY END USER 6.4.4. ASIA MEDICAL CANNABIS MARKET, BY COUNTRY 6.4.4.1. THAILAND 6.4.4.1.1. THAILAND MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.4.4.1.2. THAILAND MEDICAL CANNABIS MARKET, BY APPLICATION 6.4.4.1.3. THAILAND MEDICAL CANNABIS MARKET, BY END USER 6.4.4.2. AUSTRALIA 6.4.4.2.1. AUSTRALIA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.4.4.2.2. AUSTRALIA MEDICAL CANNABIS MARKET, BY APPLICATION 6.4.4.2.3. AUSTRALIA MEDICAL CANNABIS MARKET, BY END USER 6.4.4.3. NEW ZEALAND 6.4.4.3.1. NEW ZEALAND MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.4.4.3.2. NEW ZEALAND MEDICAL CANNABIS MARKET, BY APPLICATION 6.4.4.3.3. NEW ZEALAND MEDICAL CANNABIS MARKET, BY END USER 6.4.4.4. REST OF ASIA 6.4.4.4.1. REST OF ASIA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.4.4.4.2. REST OF ASIA MEDICAL CANNABIS MARKET, BY APPLICATION 6.4.4.4.3. REST OF ASIA MEDICAL CANNABIS MARKET, BY END USER 6.5. MIDDLE EAST & AFRICA 6.5.1. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.5.2. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION 6.5.3. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY END USER 6.5.4. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY COUNTRY 6.5.4.1. BRAZIL 6.5.4.1.1. BRAZIL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.5.4.1.2. BRAZIL MEDICAL CANNABIS MARKET, BY APPLICATION 6.5.4.1.3. BRAZIL MEDICAL CANNABIS MARKET, BY END USER 6.5.4.2. SOUTH AFRICA 6.5.4.2.1. SOUTH AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.5.4.2.2. SOUTH AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION 6.5.4.2.3. SOUTH AFRICA MEDICAL CANNABIS MARKET, BY END USER 6.5.4.3. REST OF MENA 6.5.4.3.1. REST OF MENA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.5.4.3.2. REST OF MENA MEDICAL CANNABIS MARKET, BY APPLICATION 6.5.4.3.3. REST OF MENA MEDICAL CANNABIS MARKET, BY END USER TABLE 109. REST OF MENA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION)LIST OF TABLES TABLE 01. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 02. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 03. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 04. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 06. BUDS/ MARIJUANA POWDER MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 07. NORTH AMERICA BUDS/ MARIJUANA POWDER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 08. EUROPE BUDS/ MARIJUANA POWDER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 09. ASIA BUDS/ MARIJUANA POWDER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. MIDDLE EAST & AFRICA BUDS/ MARIJUANA POWDER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 11. CANNABIS EXTRACTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 12. NORTH AMERICA CANNABIS EXTRACTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 13. EUROPE CANNABIS EXTRACTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 14. ASIA CANNABIS EXTRACTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 15. MIDDLE EAST & AFRICA CANNABIS EXTRACTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 16. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 17. CHRONIC PAIN MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 18. NORTH AMERICA CHRONIC PAIN MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 19. EUROPE CHRONIC PAIN MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. ASIA CHRONIC PAIN MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 21. MIDDLE EAST & AFRICA CHRONIC PAIN MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. MENTAL DISORDERS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 23. NORTH AMERICA MENTAL DISORDERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. EUROPE MENTAL DISORDERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. ASIA MENTAL DISORDERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 26. MIDDLE EAST & AFRICA MENTAL DISORDERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. CANCER MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 28. NORTH AMERICA CANCER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. EUROPE CANCER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. ASIA CANCER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. MIDDLE EAST & AFRICA CANCER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. OTHER APPLICATIONS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 33. NORTH AMERICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. EUROPE OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. ASIA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. MIDDLE EAST & AFRICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 38. PHARMACEUTICALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 39. NORTH AMERICA PHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. EUROPE PHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. ASIA PHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. MIDDLE EAST & AFRICA PHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. RESEARCH AND DEVELOPMENT CENTERS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 44. NORTH AMERICA RESEARCH AND DEVELOPMENT CENTERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. EUROPE RESEARCH AND DEVELOPMENT CENTERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. ASIA RESEARCH AND DEVELOPMENT CENTERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. MIDDLE EAST & AFRICA RESEARCH AND DEVELOPMENT CENTERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 49. NORTH AMERICA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($MILLION) TABLE 50. NORTH AMERICA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($MILLION) TABLE 51. NORTH AMERICA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 52. NORTH AMERICA MEDICAL CANNABIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. U.S. MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 54. U.S. MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 55. U.S. MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 56. CANADA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 57. CANADA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 58. CANADA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 59. EUROPE MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($MILLION) TABLE 60. EUROPE MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($MILLION) TABLE 61. EUROPE MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 62. EUROPE MEDICAL CANNABIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. GERMANY MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 64. GERMANY MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 65. GERMANY MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 66. U.K. MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 67. U.K. MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 68. U.K. MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 69. DENMARK MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 70. DENMARK MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 71. DENMARK MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 72. ITALY MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 73. ITALY MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 74. ITALY MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 75. POLAND MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 76. POLAND MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 77. POLAND MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 78. REST OF EUROPE MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 79. REST OF EUROPE MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 80. REST OF EUROPE MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 81. ASIA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($MILLION) TABLE 82. ASIA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($MILLION) TABLE 83. ASIA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 84. ASIA MEDICAL CANNABIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 85. THAILAND MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 86. THAILAND MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 87. THAILAND MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 88. AUSTRALIA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 89. AUSTRALIA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 90. AUSTRALIA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 91. NEW ZEALAND MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 92. NEW ZEALAND MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 93. NEW ZEALAND MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 94. REST OF ASIA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 95. REST OF ASIA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 96. REST OF ASIA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 97. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($MILLION) TABLE 98. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($MILLION) TABLE 99. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 100. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 101. BRAZIL MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 102. BRAZIL MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 103. BRAZIL MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 104. SOUTH AFRICA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 105. SOUTH AFRICA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 106. SOUTH AFRICA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 107. REST OF MENA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 108. REST OF MENA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 109. REST OF MENA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION)LIST OF FIGURES CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: GLOBAL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 3.1. OVERVIEW 3.2. BUDS/ MARIJUANA POWDER 3.2.1. BUDS/ MARIJUANA POWDER MARKET, BY REGION 3.2.1.1. NORTH AMERICA BUDS/ MARIJUANA POWDER MARKET, BY COUNTRY 3.2.1.2. EUROPE BUDS/ MARIJUANA POWDER MARKET, BY COUNTRY 3.2.1.3. ASIA BUDS/ MARIJUANA POWDER MARKET, BY COUNTRY 3.2.1.4. MIDDLE EAST & AFRICA BUDS/ MARIJUANA POWDER MARKET, BY COUNTRY 3.3. CANNABIS EXTRACTS 3.3.1. CANNABIS EXTRACTS MARKET, BY REGION 3.3.1.1. NORTH AMERICA CANNABIS EXTRACTS MARKET, BY COUNTRY 3.3.1.2. EUROPE CANNABIS EXTRACTS MARKET, BY COUNTRY 3.3.1.3. ASIA CANNABIS EXTRACTS MARKET, BY COUNTRY 3.3.1.4. MIDDLE EAST & AFRICA CANNABIS EXTRACTS MARKET, BY COUNTRY CHAPTER 4: GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION 4.1. OVERVIEW 4.2. CHRONIC PAIN 4.2.1. CHRONIC PAIN MARKET, BY REGION 4.2.1.1. NORTH AMERICA CHRONIC PAIN MARKET, BY COUNTRY 4.2.1.2. EUROPE CHRONIC PAIN MARKET, BY COUNTRY 4.2.1.3. ASIA CHRONIC PAIN MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA CHRONIC PAIN MARKET, BY COUNTRY 4.3. MENTAL DISORDERS 4.3.1. MENTAL DISORDERS MARKET, BY REGION 4.3.1.1. NORTH AMERICA MENTAL DISORDERS MARKET, BY COUNTRY 4.3.1.2. EUROPE MENTAL DISORDERS MARKET, BY COUNTRY 4.3.1.3. ASIA MENTAL DISORDERS MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA MENTAL DISORDERS MARKET, BY COUNTRY 4.4. CANCER 4.4.1. CANCER MARKET, BY REGION 4.4.1.1. NORTH AMERICA CANCER MARKET, BY COUNTRY 4.4.1.2. EUROPE CANCER MARKET, BY COUNTRY 4.4.1.3. ASIA CANCER MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA CANCER MARKET, BY COUNTRY 4.5. OTHER APPLICATIONS 4.5.1. OTHER APPLICATIONS MARKET, BY REGION 4.5.1.1. NORTH AMERICA OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.2. EUROPE OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.3. ASIA OTHER APPLICATIONS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA OTHER APPLICATIONS MARKET, BY COUNTRY CHAPTER 5: GLOBAL MEDICAL CANNABIS MARKET, BY END USER 5.1. OVERVIEW 5.2. PHARMACEUTICALS 5.2.1. PHARMACEUTICALS MARKET, BY REGION 5.2.1.1. NORTH AMERICA PHARMACEUTICALS MARKET, BY COUNTRY 5.2.1.2. EUROPE PHARMACEUTICALS MARKET, BY COUNTRY 5.2.1.3. ASIA PHARMACEUTICALS MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA PHARMACEUTICALS MARKET, BY COUNTRY 5.3. RESEARCH AND DEVELOPMENT CENTERS 5.3.1. RESEARCH AND DEVELOPMENT CENTERS MARKET, BY REGION 5.3.1.1. NORTH AMERICA RESEARCH AND DEVELOPMENT CENTERS MARKET, BY COUNTRY 5.3.1.2. EUROPE RESEARCH AND DEVELOPMENT CENTERS MARKET, BY COUNTRY 5.3.1.3. ASIA RESEARCH AND DEVELOPMENT CENTERS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA RESEARCH AND DEVELOPMENT CENTERS MARKET, BY COUNTRY CHAPTER 6: GLOBAL MEDICAL CANNABIS MARKET, BY REGION 6.1. OVERVIEW 6.2. NORTH AMERICA 6.2.1. NORTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.2.2. NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION 6.2.3. NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER 6.2.4. NORTH AMERICA MEDICAL CANNABIS MARKET, BY COUNTRY 6.2.4.1. U.S. 6.2.4.1.1. U.S. MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.2.4.1.2. U.S. MEDICAL CANNABIS MARKET, BY APPLICATION 6.2.4.1.3. U.S. MEDICAL CANNABIS MARKET, BY END USER 6.2.4.2. CANADA 6.2.4.2.1. CANADA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.2.4.2.2. CANADA MEDICAL CANNABIS MARKET, BY APPLICATION 6.2.4.2.3. CANADA MEDICAL CANNABIS MARKET, BY END USER 6.3. EUROPE 6.3.1. EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.2. EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.3. EUROPE MEDICAL CANNABIS MARKET, BY END USER 6.3.4. EUROPE MEDICAL CANNABIS MARKET, BY COUNTRY 6.3.4.1. GERMANY 6.3.4.1.1. GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.4.1.2. GERMANY MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.4.1.3. GERMANY MEDICAL CANNABIS MARKET, BY END USER 6.3.4.2. U.K. 6.3.4.2.1. U.K. MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.4.2.2. U.K. MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.4.2.3. U.K. MEDICAL CANNABIS MARKET, BY END USER 6.3.4.3. DENMARK 6.3.4.3.1. DENMARK MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.4.3.2. DENMARK MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.4.3.3. DENMARK MEDICAL CANNABIS MARKET, BY END USER 6.3.4.4. ITALY 6.3.4.4.1. ITALY MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.4.4.2. ITALY MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.4.4.3. ITALY MEDICAL CANNABIS MARKET, BY END USER 6.3.4.5. POLAND 6.3.4.5.1. POLAND MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.4.5.2. POLAND MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.4.5.3. POLAND MEDICAL CANNABIS MARKET, BY END USER 6.3.4.6. REST OF EUROPE 6.3.4.6.1. REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.3.4.6.2. REST OF EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION 6.3.4.6.3. REST OF EUROPE MEDICAL CANNABIS MARKET, BY END USER 6.4. ASIA 6.4.1. ASIA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.4.2. ASIA MEDICAL CANNABIS MARKET, BY APPLICATION 6.4.3. ASIA MEDICAL CANNABIS MARKET, BY END USER 6.4.4. ASIA MEDICAL CANNABIS MARKET, BY COUNTRY 6.4.4.1. THAILAND 6.4.4.1.1. THAILAND MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.4.4.1.2. THAILAND MEDICAL CANNABIS MARKET, BY APPLICATION 6.4.4.1.3. THAILAND MEDICAL CANNABIS MARKET, BY END USER 6.4.4.2. AUSTRALIA 6.4.4.2.1. AUSTRALIA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.4.4.2.2. AUSTRALIA MEDICAL CANNABIS MARKET, BY APPLICATION 6.4.4.2.3. AUSTRALIA MEDICAL CANNABIS MARKET, BY END USER 6.4.4.3. NEW ZEALAND 6.4.4.3.1. NEW ZEALAND MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.4.4.3.2. NEW ZEALAND MEDICAL CANNABIS MARKET, BY APPLICATION 6.4.4.3.3. NEW ZEALAND MEDICAL CANNABIS MARKET, BY END USER 6.4.4.4. REST OF ASIA 6.4.4.4.1. REST OF ASIA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.4.4.4.2. REST OF ASIA MEDICAL CANNABIS MARKET, BY APPLICATION 6.4.4.4.3. REST OF ASIA MEDICAL CANNABIS MARKET, BY END USER 6.5. MIDDLE EAST & AFRICA 6.5.1. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.5.2. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION 6.5.3. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY END USER 6.5.4. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY COUNTRY 6.5.4.1. BRAZIL 6.5.4.1.1. BRAZIL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.5.4.1.2. BRAZIL MEDICAL CANNABIS MARKET, BY APPLICATION 6.5.4.1.3. BRAZIL MEDICAL CANNABIS MARKET, BY END USER 6.5.4.2. SOUTH AFRICA 6.5.4.2.1. SOUTH AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.5.4.2.2. SOUTH AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION 6.5.4.2.3. SOUTH AFRICA MEDICAL CANNABIS MARKET, BY END USER 6.5.4.3. REST OF MENA 6.5.4.3.1. REST OF MENA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 6.5.4.3.2. REST OF MENA MEDICAL CANNABIS MARKET, BY APPLICATION 6.5.4.3.3. REST OF MENA MEDICAL CANNABIS MARKET, BY END USER TABLE 01. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 02. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 03. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 04. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 06. BUDS/ MARIJUANA POWDER MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 07. NORTH AMERICA BUDS/ MARIJUANA POWDER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 08. EUROPE BUDS/ MARIJUANA POWDER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 09. ASIA BUDS/ MARIJUANA POWDER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. MIDDLE EAST & AFRICA BUDS/ MARIJUANA POWDER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 11. CANNABIS EXTRACTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 12. NORTH AMERICA CANNABIS EXTRACTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 13. EUROPE CANNABIS EXTRACTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 14. ASIA CANNABIS EXTRACTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 15. MIDDLE EAST & AFRICA CANNABIS EXTRACTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 16. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 17. CHRONIC PAIN MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 18. NORTH AMERICA CHRONIC PAIN MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 19. EUROPE CHRONIC PAIN MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. ASIA CHRONIC PAIN MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 21. MIDDLE EAST & AFRICA CHRONIC PAIN MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. MENTAL DISORDERS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 23. NORTH AMERICA MENTAL DISORDERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. EUROPE MENTAL DISORDERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. ASIA MENTAL DISORDERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 26. MIDDLE EAST & AFRICA MENTAL DISORDERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. CANCER MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 28. NORTH AMERICA CANCER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. EUROPE CANCER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. ASIA CANCER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. MIDDLE EAST & AFRICA CANCER MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. OTHER APPLICATIONS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 33. NORTH AMERICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. EUROPE OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. ASIA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. MIDDLE EAST & AFRICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 38. PHARMACEUTICALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 39. NORTH AMERICA PHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. EUROPE PHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. ASIA PHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. MIDDLE EAST & AFRICA PHARMACEUTICALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. RESEARCH AND DEVELOPMENT CENTERS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 44. NORTH AMERICA RESEARCH AND DEVELOPMENT CENTERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. EUROPE RESEARCH AND DEVELOPMENT CENTERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. ASIA RESEARCH AND DEVELOPMENT CENTERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. MIDDLE EAST & AFRICA RESEARCH AND DEVELOPMENT CENTERS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. GLOBAL MEDICAL CANNABIS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 49. NORTH AMERICA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($MILLION) TABLE 50. NORTH AMERICA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($MILLION) TABLE 51. NORTH AMERICA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 52. NORTH AMERICA MEDICAL CANNABIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. U.S. MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 54. U.S. MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 55. U.S. MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 56. CANADA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 57. CANADA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 58. CANADA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 59. EUROPE MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($MILLION) TABLE 60. EUROPE MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($MILLION) TABLE 61. EUROPE MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 62. EUROPE MEDICAL CANNABIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. GERMANY MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 64. GERMANY MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 65. GERMANY MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 66. U.K. MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 67. U.K. MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 68. U.K. MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 69. DENMARK MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 70. DENMARK MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 71. DENMARK MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 72. ITALY MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 73. ITALY MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 74. ITALY MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 75. POLAND MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 76. POLAND MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 77. POLAND MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 78. REST OF EUROPE MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 79. REST OF EUROPE MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 80. REST OF EUROPE MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 81. ASIA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($MILLION) TABLE 82. ASIA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($MILLION) TABLE 83. ASIA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 84. ASIA MEDICAL CANNABIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 85. THAILAND MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 86. THAILAND MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 87. THAILAND MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 88. AUSTRALIA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 89. AUSTRALIA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 90. AUSTRALIA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 91. NEW ZEALAND MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 92. NEW ZEALAND MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 93. NEW ZEALAND MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 94. REST OF ASIA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 95. REST OF ASIA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 96. REST OF ASIA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 97. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($MILLION) TABLE 98. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($MILLION) TABLE 99. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($MILLION) TABLE 100. MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 101. BRAZIL MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 102. BRAZIL MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 103. BRAZIL MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 104. SOUTH AFRICA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 105. SOUTH AFRICA MEDICAL CANNABIS MARKET VALUE, BY APPLICATION, 2023-2030, ($ MILLION) TABLE 106. SOUTH AFRICA MEDICAL CANNABIS MARKET VALUE, BY END USER, 2023-2030, ($ MILLION) TABLE 107. REST OF MENA MEDICAL CANNABIS MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 108. REST OF MENA MEDICAL CANNABIS MARKET VALUE, BY AP